Photo via CBS News

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

Read the original at CBS News ↗
Cite

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces. (2026, November 10). CBS News. https://www.cbsnews.com/video/glp-1-include-warning-potential-increased-risk-vision-loss-fda-announces/

Dated from the outlet's own feed. Check the original for its byline.

CBS News · collected 2026-11-10

Quick Summary

It appears there might be a mismatch between the title and the article text provided. The title discusses the FDA announcing that GLP-1 drugs must now carry warnings about an increased risk of vision loss. However, the text given is unrelated and mentions Hegseth being accused of high crimes and misdemeanors. Without the relevant content discussing GLP-1 drugs or FDA regulations, I cannot summarize the specific report on medications as requested.
Written by AI on 2026-11-10, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

As of November 9, 2026, the U.S. Food and Drug Administration (FDA) has mandated that makers of GLP-1 weight-loss drugs such as Ozempic and Zepbound must include warnings about a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to permanent vision loss. Roughly 28 million Americans are currently taking these medications, according to a July Gallup poll. The FDA's decision follows research indicating that GLP-1 drugs may increase the risk of NAION; for instance, a 2024 study in JAMA Ophthalmology found that diabetes patients prescribed semaglutide were four times as likely to develop NAION compared to those not taking the drug. Spokespeople from drug manufacturers Novo Nordisk and Eli Lilly emphasized their commitment to patient safety.

Written for “FDA Warning On GLP-1s Eye Risk” on 2026-11-10, grounded in this article and the 3 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political question, so it has no leaning score. That is an answer rather than a gap: a match report or a rescue can be warmly or critically written without being left or right, and scoring it anyway is how approval of a subject gets recorded as a political position.
No political leaning scored for article 140325 · logged 2026-11-10

Story

FDA Warning On GLP-1s Eye Risk
Health · 4 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
The Independent
Hedges 1 of 4 claims Outlet record 59/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
1
sentences that state something as happening or true
Uncertain
0%
0 of 1 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
68/100
CBS News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
4
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-10 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBS News · 5052 article(s) · 9 correction(s) detected
Running correction rate · 9 correction(s)

Who wrote this

No reporter is named on this article.

Topics

No topics tagged.

Subjects

Hegseth PERSON · 1×

Narrative

Hegseth accused of high crimes, misdemeanors
framing: assertive · carried by 1 article(s) · first seen 2026-11-10

Claims (1 extracted, 0 hedged)

Hegseth accused of high crimes, misdemeanors asserted
Hegseth → accuse → crimes
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support